Tafasitamab

ATC L01FX12 · 9 markets · 12 records

Tafasitamab 9 markets · 12 records Forms

AU 3 records · 2 strengths

200 mginjectionMINJUVI+1MINJUVI tafasitamab 200 mg powder for solution for infusion 1 vial per carton also in GB·ES·TW +1 unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名MINJUVI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 2 records · 1 strengths

200 mg/5 mLinjectionMONJUVI

GB 1 records · 1 strengths

200 mginjectionMinjuvi 200mg powder for concentrate for solution for infusion vials also in AU·ES·TW +1

CA 1 records · 1 strengths

200 mgpowderMINJUVI

ES 1 records · 1 strengths

200 mginjectionMINJUVI also in AU·GB·TW +1

TW 1 records · 1 strengths

200 mginjectionMinjuvi powder for concentrate for solution for infusion 200 mg+1明諾凱凍晶乾燥注射劑200毫克 also in AU·GB·ES +1

HK 1 records · 1 strengths

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Minjuvi powder for concentrate for solution for infusion 200 mg ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名MINJUVI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 strengths

200 mginjectionMINJUVI 200 mg, poudre pour solution à diluer pour perfusion also in AU·GB·ES +1

Side-by-side table

Strength / form / release	US	GB	CA	AU	ES	TW	HK	EU	FR
200 mg injection	not recorded	Minjuvi 200mg powder for concentrate for solution for infusion vials	not recorded	MINJUVI MINJUVI tafasitamab 200 mg powder for solution for infusion 1 vial per carton	MINJUVI	Minjuvi powder for concentrate for solution for infusion 200 mg 明諾凱凍晶乾燥注射劑200毫克	not recorded	not recorded	MINJUVI 200 mg, poudre pour solution à diluer pour perfusion
200 mg/5 mL injection	MONJUVI	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
200 mg powder	not recorded	not recorded	MINJUVI	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	MINJUVI	not recorded	not recorded	Minjuvi powder for concentrate for solution for infusion 200 mg	MINJUVI	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录（未在本表显示）。另有 1 個規格/劑型僅在 CA 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.